Nutraland USA, Inc. today announced results from a peer-reviewed pilot clinical study showing that Somato® Tomato Fruit Extract, standardized to 5% Phytomelatonin, helped participants fall asleep faster and improved emotional well-being. The study, just e-published ahead of print in Alternative Therapies in Health & Medicine, provides real-world evidence that a plant-based sleep solution can support natural sleep rhythms. The full study can be viewed via PubMed here: https://pubmed.ncbi.nlm.nih.gov/40985949/.
“We’re excited by these findings, which demonstrate that our whole food-derived Phytomelatonin can meaningfully improve sleep and well-being,” said Dr. Gene Bruno, Chief Scientific Officer of Nutraland USA. “What makes the results especially compelling is the consistent correlation between wearable data and self-reported outcomes. Together, they suggest that Somato® has real potential as a natural, plant-based solution for better sleep.”
In this open-label pilot trial, participants took a daily oral strip delivering 2 mg of Somato® Phytomelatonin. Results showed:• 33% reduction in sleep latency
• Improved overall sleep efficiency / quality
• Decreased time awake during the night
• Self-reported improvements in emotional well-being and global quality-of-life metrics
Somato® was well tolerated, with no serious adverse effects reported during the study. Its plant-based Phytomelatonin works in harmony with the body’s own melatonin production, providing a safe, natural sleep solution that consumers can feel confident using.
These initial results position Somato® as an innovative, plant-based alternative to synthetic melatonin for supporting better sleep. Nutraland USA plans to follow up on these positive findings with a larger, randomized, placebo-controlled study – the “gold standard” of clinical research.
